Table 1.

ADC values of tumour entities and subgroups at baseline and during follow-up

	ADC baseline	ADC follow-up
NB all	n = 15	n = 11
	0.76 ± 0.11	0.89 ± 0.29
	(0.58–0.95)	(0.49–1.49)
GNB + GN	n = 4	n = 2
	1.47 ± 0.23	GNB 0.90
	(1.15–1.69)	GN 1.84
NB with therapy	n = 6	n = 5
	0.70 ± 0.08	0.71 ± 0.25
	(0.58–0.79)	(0.49–1.14)
NB with observation	n = 7	n = 4
	0.82 ± 0.09	0.93 ± 0.12
	(0.65–0.95)	(0.77–1.06)
NB with risk factors	n = 6	n = 5
	0.70 ± 0.08	0.72 ± 0.25
	(0.58–0.79)	(0.78–1.50)
NB without risk factors	n = 9	n = 7
	0.79 ± 0.11	1.04 ± 0.23
	(0.59–0.95)	(0.77–1.50)

ADC apparent diffusion coefficient, GN ganglioneuroma, GNB ganglioneuroblastoma, NB neuroblastoma

Data is presented as mean ± standard deviation and range (minimum–maximum)